S. 4390 · 117th Congress
Accelerated Approval Transparency Act
- Stage
- In committee
- Sponsor
- John Hickenlooper
- Introduced
- 2022-06-14
- Latest action
- 2022-06-14 · Introduced in Senate
Summary
Accelerated Approval Transparency Act
This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.